Spes Immunotherapeutics
PrivateCompany Overview
Spes Immunotherapeutics is a biotechnology company that develops personalized therapeutic vaccines to prevent leukemia relapse in children.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Spes Immunotherapeutics Comparables
Compare Spes Immunotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kindling Bio | 75% | |
| BioNTech SE | 70% | |
| Evaxion A/S | 68% |
Spes Immunotherapeutics Funding Rounds
Historical fundraising activity
Spes Immunotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Spes Immunotherapeutics's valuation, stock price, and market status.
Is Spes Immunotherapeutics a public or private company?
Spes Immunotherapeutics is a private company.
What is the current stock price of Spes Immunotherapeutics?
Spes Immunotherapeutics is a private company with no public stock price. Caplight tracks Spes Immunotherapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Spes Immunotherapeutics worth (valuation)?
Valuation information for Spes Immunotherapeutics is not publicly available.
Can I buy Spes Immunotherapeutics stock?
Spes Immunotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Spes Immunotherapeutics's last funding round?
Funding round information for Spes Immunotherapeutics is not publicly available.
Who are the main investors in Spes Immunotherapeutics?
Investor information for Spes Immunotherapeutics is not publicly disclosed.
Will Spes Immunotherapeutics IPO soon?
No public IPO plans have been announced for Spes Immunotherapeutics.
How can I track Spes Immunotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Spes Immunotherapeutics's secondary market activity and sign up for updates.